Real-time
Euronext Bruxelles
09:10:22 2024-06-13 am EDT
|
5-day change
|
1st Jan Change
|
93.31
EUR
|
-1.50%
|
|
+2.22%
|
-1.03%
|
Fiscal Period: December |
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
9,980
|
9,968
|
-
|
-
|
Enterprise Value (EV)
1 |
11,564
|
11,146
|
10,972
|
10,715
|
P/E ratio
|
51.8
x
|
16.9
x
|
13.6
x
|
11.9
x
|
Yield
|
1.72%
|
1.74%
|
1.86%
|
2.03%
|
Capitalization / Revenue
|
1.46
x
|
1.47
x
|
1.38
x
|
1.31
x
|
EV / Revenue
|
1.69
x
|
1.64
x
|
1.52
x
|
1.41
x
|
EV / EBITDA
|
7.15
x
|
7.46
x
|
6.66
x
|
6.01
x
|
EV / FCF
|
25.8
x
|
35.3
x
|
27.1
x
|
20.4
x
|
FCF Yield
|
3.87%
|
2.83%
|
3.69%
|
4.89%
|
Price to Book
|
1.32
x
|
1.25
x
|
1.18
x
|
1.1
x
|
Nbr of stocks (in thousands)
|
105,876
|
105,221
|
-
|
-
|
Reference price
2 |
94.26
|
94.73
|
94.73
|
94.73
|
Announcement Date
|
3/12/24
|
-
|
-
|
-
|
Fiscal Period: December |
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
6,834
|
6,797
|
7,210
|
7,624
|
EBITDA
1 |
1,618
|
1,494
|
1,646
|
1,783
|
EBIT
1 |
1,134
|
1,013
|
1,144
|
1,269
|
Operating Margin
|
16.59%
|
14.91%
|
15.86%
|
16.64%
|
Earnings before Tax (EBT)
1 |
389
|
788.7
|
921.8
|
1,042
|
Net income
1 |
193
|
563.3
|
696.5
|
796.2
|
Net margin
|
2.82%
|
8.29%
|
9.66%
|
10.44%
|
EPS
2 |
1.820
|
5.616
|
6.961
|
7.992
|
Free Cash Flow
1 |
448
|
315.6
|
405
|
524.1
|
FCF margin
|
6.56%
|
4.64%
|
5.62%
|
6.87%
|
FCF Conversion (EBITDA)
|
27.69%
|
21.12%
|
24.6%
|
29.4%
|
FCF Conversion (Net income)
|
232.12%
|
56.04%
|
58.14%
|
65.83%
|
Dividend per Share
2 |
1.620
|
1.650
|
1.765
|
1.920
|
Announcement Date
|
3/12/24
|
-
|
-
|
-
|
Fiscal Period: December |
2023 Q4
|
2023 S2
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2024 S2
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
1,577
|
-
|
1,624
|
1,766
|
3,370
|
1,772
|
1,755
|
3,464
|
1,617
|
1,814
|
EBITDA
1 |
294
|
-
|
363
|
391.5
|
747
|
419.6
|
371.4
|
774.5
|
562
|
380.8
|
EBIT
1 |
-
|
457
|
252
|
279.3
|
523
|
303.8
|
268.4
|
557
|
562
|
253.3
|
Operating Margin
|
-
|
-
|
15.52%
|
15.82%
|
15.52%
|
17.14%
|
15.29%
|
16.08%
|
34.75%
|
13.96%
|
Earnings before Tax (EBT)
1 |
-
|
59
|
-
|
209
|
360
|
236
|
174
|
410
|
-
|
-
|
Net income
1 |
-
|
-106
|
-
|
155
|
256
|
174
|
155
|
330
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
8.78%
|
7.6%
|
9.82%
|
8.83%
|
9.53%
|
-
|
-
|
EPS
2 |
-
|
-
|
-
|
1.860
|
-
|
2.036
|
1.744
|
-
|
5.314
|
1.502
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
1.620
|
-
|
-
|
-
|
Announcement Date
|
3/12/24
|
3/12/24
|
5/16/24
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
1,584
|
1,179
|
1,004
|
747
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.979
x
|
0.7886
x
|
0.6098
x
|
0.4189
x
|
Free Cash Flow
1 |
448
|
316
|
405
|
524
|
ROE (net income / shareholders' equity)
|
12%
|
8.1%
|
9.29%
|
9.7%
|
ROA (Net income/ Total Assets)
|
5.67%
|
4.12%
|
5.63%
|
6%
|
Assets
1 |
3,404
|
13,676
|
12,375
|
13,275
|
Book Value Per Share
2 |
71.50
|
75.50
|
80.50
|
86.30
|
Cash Flow per Share
2 |
12.00
|
8.460
|
11.00
|
12.20
|
Capex
1 |
848
|
643
|
765
|
792
|
Capex / Sales
|
12.41%
|
9.47%
|
10.6%
|
10.39%
|
Announcement Date
|
3/12/24
|
-
|
-
|
-
|
Last Close Price
94.73
EUR Average target price
108.7
EUR Spread / Average Target +14.71% Consensus |
1st Jan change
|
Capi.
|
---|
| -1.03% | 10.81B | | +5.02% | 78.96B | | -6.11% | 45B | | +4.68% | 33.67B | | +13.39% | 18.76B | | +15.66% | 12.22B | | -21.29% | 10.45B | | -3.32% | 9.1B | | -3.28% | 8.41B | | -13.07% | 5.86B |
Diversified Chemicals
|